National Comprehensive Cancer Network



NCCN Oncology Research Program (ORP)
NCCN ORP Recent News
NCCN ORP Affiliate Research Consortium
NCCN ORP Scientific Publications
NCCN ORP for Industry
NCCN ORP Investigator Steering Committee
NCCN ORP Testimonials
NCCN Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
NCCN ORP Grant History
NCCN Informed Consent Language Database
NCCN Specialized Imaging Research Consortium™ (SIRC)
NCCN ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources


Roswell Park Cancer Institute
Buffalo, New York
877.275.7724 (877.ASK.RPCI)
www.roswellpark.org

Adult Oncology Services

Dr. Roswell Park, the founder of Roswell Park Cancer Institute (RPCI), was one of the nation's most pre-eminent surgeons and arguably the first to articulate the importance of translational research in a cancer center. His revolutionary model of a "multidisciplinary approach" to cancer with scientists and clinicians working in concert and in consult has become the standard by which all modern-day comprehensive cancer centers are measured.

Decisions made at the time of diagnosis and with recurrent disease demand multidisciplinary input to assure the selection of a "best practice" treatment plan for the patient. RPCI's cancer program is disease-specific, with teams working together to develop a comprehensive, individualized care program for each patient from diagnosis, through treatment and rehabilitation, to discharge and follow-up care.

Multidisciplinary Teams

The faculty of RPCI is organized into disease-specific, multidisciplinary teams, with broad representation from clinical care and research, as well as basic and applied science. These teams of specialists work in common locations known as "Centers", which are conveniently located within the Hospital (see Multidisciplinary Centers, below).

Special Expertise

Translational Research

Investigator-initiated Phase I Clinical Research Studies

Immunotherapies: Vaccines and Other New Agents

Minimally Invasive Surgery (includes robot-assisted surgery, video-assisted thoracic surgery, radiofrequency ablation, Gamma Knife radiosurgery, brachytherapy, etc.)

Photodynamic Therapy and the Development of New Imaging Agents

Blood and Marrow Transplant

Treatment of Complex Cancers

Radiation for Treatment of Head & Neck Cancers

Lung Cancer Screening/Early Detection for High-Risk Individuals

Pathology

Diagnostic Radiology

Data Bank and BioRepository

Genetics

Maxillofacial Prosthetics

Pain Management

Vitamin D Studies

Cancer Health Disparities Research

Tobacco Control/Cessation

Chemoprevention Studies

General Information

General Information

877.275.7724 (877.ASK.RPCI)

www.roswellpark.org

Referring Physician/Self-Referral Line

800.767.9355 (800.ROSWELL)

Location

Buffalo, NY

Facility

RPCI's campus on the Buffalo Niagara Medical Campus includes approximately 1.5 million square feet of space equally distributed between clinical programs and research/education functions.

Travel Assistance

Travel assistance is coordinated through the Department of Psychosocial Oncology

Lodging

Lodging may be coordinated through the Departments of Psychosocial Oncology and Case Management, or by the patient/family. Available lodging includes The DoubleTree Club Hotel, which is adjacent to RPCI, and The Kevin Guest House, the nation's first hospitality house, which offers affordable housing to RPCI patients, including BMT patients, and their families.

Treatment

Multidisciplinary Centers

All Disease Centers listed below may be contacted by calling 800.767.9355 (800.ROSWELL):

Blood & Marrow Transplant

Breast

Chemotherapy/Infusion

Dental/Maxillofacial

Dermatology

Gastrointestinal

Genitourinary

Gynecology

Head & Neck

Leukemia

Lymphoma

Melanoma

Multiple Myeloma

Neuro-Oncology

Pediatrics

Sarcoma

Thoracic

Hematopoietic Stem Cell Transplant Program

Selected malignant and non-malignant hematologic disorders and solid tumors, including those listed below, are treated with autologous, or allogeneic hematopoietic stem cell transplants utilizing blood, bone marrow or cord blood

Amyloidosis

Aplastic Anemia

Acute Lymphoblastic and Myelogenous Leukemias

Chronic Lymphocytic and Myelogenous Leukemias

Ewing Sarcoma

Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Neuroblastoma

Testicular Cancer/Germ Cell Tumors

Immunodeficiency Disorders

Alternative/Complementary Medicine

Cancer Prevention

Prevention research examines behaviors, environmental exposures and genetics as they relate to cancer and treatment outcomes. A major challenge in prevention and control of cancer is to identify those persons who are at greatest risk of developing cancer to help them alter their risk and/or receive adequate screening for early detection. RPCI also works to identify predictors of recurrence after diagnosis and treatment so as to enhance cancer survival and patient quality of life.

A major focus of the program is devoted to research on ways to promote prevention and cessation of tobacco use. Recognized as an NIH-supported Transdisciplinary Tobacco Use Research Center of Excellence, RPCI's Tobacco Control Program focuses on how policy in developing and industrialized societies can lessen tobacco dependence. RPCI also operates the New York State Smokers' Quitline at 1-866-NY-QUITS (1-866-697-8487) and runs local tobacco control initiatives sponsored by the New York State Department of Health.

A concentrated commitment to translational research by building prevention linkages to basic science distinguishes the prevention program at RPCI. To explore scientific leads and develop more effective strategies, prevention experts collaborate with researchers from genetics, biochemistry, pharmacology, toxicology, and immunology.

RPCI clinicians work with primary care doctors, nurses, and other health care professionals in the community to enhance cancer control and screening to track cancer patterns, and to develop clinical interventions for prevention.

A critical resource for the program, the Western New York Data Bank and BioRepository (DBBR) collects and provides de-identified biospecimens and associated epidemiological and clinical data to meet the scientific needs of investigators.  With its creation in 2003, the DBBR addresses what researchers across the nation have identified as the single greatest need in translational research access to high-quality biological samples. An extensive data collection and management system is in place to track informed consent, questionnaire collection and follow up, epidemiological questionnaire data, clinical data, biospecimens and their derivatives.

RPCI's Disease-site Research Groups (DSRGs), formed to prioritize clinical trials and the use of research tissues in the DBBR, bring together scientists and clinicians to provide a scientific basis for the treatment of specific cancers and to collaborate and explore new concepts in treatment for these diseases.

The mission of the Office of Cancer Health Disparities Research is to understand, reduce, eliminate and prevent cancer disparities in vulnerable and medically underserved populations and patients through trans-disciplinary research and programs.

 

Examples of Support Services:

  • Art and Music Therapy
  • Case Management
  • Cancer Information Services: Trained cancer information specialists answer general questions about cancer or RPCI services by phone: 1-877-ASK- RPCI (1-877-275-7724) or by email: askrpci@roswellpark.org). Available Monday-Friday, 9:00am-5:30pm.
  • Community Cancer Resource Center provides appropriate, accurate, up-to-date information on cancer screening, prevention, diagnosis, treatment, clinical trials, and supportive care. Also provides free wigs, hats and scarves, a lending library of books, movies, music and audiobooks; loan of laptops to inpatients; and other resources and amenities.
  • Caregiver Support
  • Concierge Services
  • Genetic Counseling & Testing
  • Home Care/Hospice
  • Just Breathe (smoking cessation program for patients and their families)
  • Long-term Survivors Clinic
  • Nutrition & Food Services
  • Patient Navigator Program
  • Pain Management
  • Palliative and End-of-Life Support
  • Psychosocial Support
  • Cancer Support Groups
  • Rehabilitation includes physical therapy, occupational therapy, respiratory therapy, nausea and fatigue management, speech therapy, and lymphedema management
  • Pastoral Care supports the concept of holistic medicine.
  • Pet Therapy

    For more information on any of the services above, call 1-877-ASK- RPCI (1-877-275-7724) or visit www.roswellpark.org.

 

Special Expertise

Cooperative Group Membership

Cooperative Group Membership List

CALGB

RTOG

ACOS

CTSU

GOG

COG

SWOG

NSABP

Activities in Cooperative Group

RPCI houses the GOG Statistical Office

Average Number of Adult Clinical Trials

In 2010, RPCI had a total of 700 active clinical research studies. This includes 242 intervention studies and 265 non-intervention studies.

During the same CY, RPCI had 66 phase I clinical research studies, and 45 were RPCI-investigator-initiated.

Clinical and Research Efforts

The collaboration and regular contact between clinicians and scientists encourage translational research and the development of new investigator-driven clinical trials that afford patients a wider range of treatment options, and ultimately lead to better approaches and improved technologies to reduce the cancer burden.

Adult Oncology Program*

No. of Inpatient Beds (Medical/Surgical)

No. of Admissions

Average Length of Stay (days)

No. of New Outpatients

No. of Oncologists (Medical and Surgical)

121**

5,156

7.1 days

8,478

165

*Figures reflect RPCI activity from April 1, 2010 through March 31, 2011.
**Number of beds in service as of 12/31/2012.